Effectiveness of Photo-biomodulation in the Treatment of Chemotherapy Induced Mucositis
Primary Purpose
Mucositis
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Simpler diode laser
Conventional symptomatic treatment
Sponsored by
About this trial
This is an interventional treatment trial for Mucositis focused on measuring mucositis - leukemia - chemotherapy
Eligibility Criteria
Inclusion Criteria:
- children diagnosed with mucositis and receiving chemotherapy
Exclusion Criteria:
- diabetes
- trismus
Sites / Locations
- Faculty of Dentistry, Alexandria University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Laser irradiation (Test group)
Conventional treatment (Control group
Arm Description
laser irradiation over lesion
Outcomes
Primary Outcome Measures
Self-reported pain level
Participants were asked to report the degree of pain. This was assessed using the visual analogue scale (VAS) which ranges from zero (lowest score) to 10 (highest score). Higher scores indicate higher pain level.
Oral mucositis lesion size
This was assessed using the World Health Organization oral mucositis lesion score Grade 0: no oral mucositis. Grade1: Presence of soreness and erythema. Grade 2: Presence of painful erythema and ulcerations that do not affect the patient solid food intake.
Grade3: Confluent ulceration that affect the solid food intake and require liquid diet.
Grade 4: The patient requires parenteral nutrition.
Secondary Outcome Measures
Full Information
NCT ID
NCT05181943
First Posted
December 20, 2021
Last Updated
December 20, 2021
Sponsor
Alexandria University
1. Study Identification
Unique Protocol Identification Number
NCT05181943
Brief Title
Effectiveness of Photo-biomodulation in the Treatment of Chemotherapy Induced Mucositis
Official Title
EFFECTIVNESS OF PHOTO BIO-MODULATION IN THE TREATMENT OF CHEMOTHERAPY INDUCED ORAL MUCOSITIS IN CHILDREN WITH ACUTE LEUKEMIA Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
November 1, 2021 (Actual)
Study Completion Date
December 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Alexandria University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the current study was to study the effect of diode laser in the treatment of chemotherapy induced mucositis in young patients suffering from leukemia
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mucositis
Keywords
mucositis - leukemia - chemotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Laser irradiation (Test group)
Arm Type
Experimental
Arm Description
laser irradiation over lesion
Arm Title
Conventional treatment (Control group
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
Simpler diode laser
Intervention Description
Non-contacting irradiation for 30 seconds on three intraoral sites repeated four times
Intervention Type
Drug
Intervention Name(s)
Conventional symptomatic treatment
Intervention Description
Conventional treatment using oracure, BBC spray, miconaz three times daily
Primary Outcome Measure Information:
Title
Self-reported pain level
Description
Participants were asked to report the degree of pain. This was assessed using the visual analogue scale (VAS) which ranges from zero (lowest score) to 10 (highest score). Higher scores indicate higher pain level.
Time Frame
up to 2 weeks
Title
Oral mucositis lesion size
Description
This was assessed using the World Health Organization oral mucositis lesion score Grade 0: no oral mucositis. Grade1: Presence of soreness and erythema. Grade 2: Presence of painful erythema and ulcerations that do not affect the patient solid food intake.
Grade3: Confluent ulceration that affect the solid food intake and require liquid diet.
Grade 4: The patient requires parenteral nutrition.
Time Frame
up to 2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
children diagnosed with mucositis and receiving chemotherapy
Exclusion Criteria:
diabetes
trismus
Facility Information:
Facility Name
Faculty of Dentistry, Alexandria University
City
Alexandria
ZIP/Postal Code
21527
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effectiveness of Photo-biomodulation in the Treatment of Chemotherapy Induced Mucositis
We'll reach out to this number within 24 hrs